Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;20(12):729-748.
doi: 10.1038/s41574-024-01024-5. Epub 2024 Aug 15.

International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

Affiliations
Review

International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

Ruth T Casey et al. Nat Rev Endocrinol. 2024 Dec.

Erratum in

  • Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
    Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Taïeb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. Casey RT, et al. Nat Rev Endocrinol. 2024 Dec;20(12):760. doi: 10.1038/s41574-024-01034-3. Nat Rev Endocrinol. 2024. PMID: 39191988 No abstract available.
  • Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
    Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Taïeb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. Casey RT, et al. Nat Rev Endocrinol. 2025 Oct;21(10):656. doi: 10.1038/s41574-025-01167-z. Nat Rev Endocrinol. 2025. PMID: 40804506 No abstract available.

Abstract

Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and adolescence. Up to 70-80% of childhood PPGL are hereditary, accounting for a higher incidence of metastatic and/or multifocal PPGL in paediatric patients than in adult patients. Key differences in the tumour biology and management, together with rare disease incidence and therapeutic challenges in paediatric compared with adult patients, mandate close expert cross-disciplinary teamwork. Teams should ideally include adult and paediatric endocrinologists, oncologists, cardiologists, surgeons, geneticists, pathologists, radiologists, clinical psychologists and nuclear medicine physicians. Provision of an international Consensus Statement should improve care and outcomes for children and adolescents with these tumours.

PubMed Disclaimer

Conflict of interest statement

Competing interests R.T.C. has received a Novartis speaker honorarium and is in an editorial position in Clinical Endocrinology. C.J. has received funding to his institution from Lantheus, Progenics, Exelixis, Merck Sharpe and Dohme and is a clinical adviser for Lantheus and Merck Sharpe and Dohme. S.D.M. is the Director of the NIHR Clinical Research Facility at Great Ormond Street Hospital, London. D.T. has received speaker and attendance honoraria from AAA/NOVARTIS. M.F. is an unpaid member of the ExCo of the European Society of Endocrinology. J.W.M.L. is an unpaid member of the advisory board of the Phaeochromocytoma and Paraganglioma Alliance.

References

    1. Bausch, B. et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr. Relat. Cancer 21, 17–25 (2014). - PubMed
    1. Ciftci, A. O., Tanyel, F. C., Şenocak, M. E. & Büyükpamukçu, N. Pheochromocytoma in children. J. Pediatr. Surg. 36, 447–452 (2001). - PubMed
    1. Hume, D. M. Pheochromocytoma in the adult and in the child. Am. J. Surg. 99, 458–496 (1960). - PubMed
    1. Wyszyńska, T., Cichocka, E., Wieteska‐Klimczak, A., Jobs, K. & Januszewicz, P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. 81, 244–246 (1992). - PubMed
    1. Barontini, M., Levin, G. & Sanso, G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann. N. Y. Acad. Sci. 1073, 30–37 (2006). - PubMed

Publication types

LinkOut - more resources